Opna Bio raised €37M in a Series A round in Nov 2022. The company is based in Epalinges, Switzerland. Investors in the round: Longitude Capital, Menlo Ventures, Northpond Ventures. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
